Pacific Biosciences of California Inc
Research Pacific Biosciences of California Inc (PACB) on Bullrun: market cap USD 537.34M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPACB
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 537.34M
- Financial periodFY2025
- RevenueUSD 160.01M
- Revenue growth3.9%
- Net income-USD 546.40M
- Free cash flow-USD 113.92M
- Gross margin28.6%
Valuation Snapshot
latest market cap is USD 537.34M.
About Pacific Biosciences of California Inc
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-read sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases.
Frequently asked questions
What is Pacific Biosciences of California Inc's market cap?
Pacific Biosciences of California Inc's market capitalization is USD 537.34M.
What does Pacific Biosciences of California Inc do?
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-read sequencing;